---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-003312"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2022-09-02T23:59:59+00:00"
generated_at: "2026-06-23T16:34:04.819732+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Entera Bio enters into $5M ATM equity facility with SVB; terminates prior B. Riley ATM

## Summary
- Entered Sales Agreement with SVB Securities for at-the-market offering of up to 5,000,000 ordinary shares.
- Agent commission set at 3.0% of gross sales price per ordinary share sold.
- Prior B. Riley Securities ATM terminated effective Aug 30, 2022; no shares were sold under it.
- Net proceeds planned for general corporate purposes including R&D, clinical trials, and working capital.

## SEC filing metadata
- accession: 0001178913-22-003312
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2022-09-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/0001178913-22-003312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/zk2228415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-003312
- JSON: https://secwatch.observer/filing/0001178913-22-003312.json
- Plain text: https://secwatch.observer/filing/0001178913-22-003312.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.